GPT Healthcare Limited IPO: Issue Price, Listing Gain and Share Price Now
GPT Healthcare Limited listed on 29-Feb-2024 at ₹200.75 against an issue price of ₹186 , a listing gain of +7.93%. It last traded at ₹151.45. This page is the record of that issue and what has happened to it since — reported figures only.
GPT Healthcare Limited IPO: listing gain and return since
| Measure | Value |
|---|---|
| Issue price | ₹186 |
| Listing price (listing-day close) | ₹200.75 |
| Listing gain | +7.93% |
| Price now | ₹151.45 |
| Change from issue price | -18.58% |
| Change from listing-day close | -24.56% |
The two changes above answer different questions and are routinely opposite in sign. The change from the issue price is what an allottee has made. The change from the listing-day close is what somebody who bought on the first day has made.
GPT Healthcare Limited IPO details
| Issue term | Detail |
|---|---|
| Issue price (upper band) | ₹186 |
| Issue size | ₹525.14 Cr |
| Fresh issue | ₹40 Cr |
| Offer for sale | ₹485.14 Cr |
| Issue opened | 22-Feb-2024 |
| Issue closed | 26-Feb-2024 |
| Listed on | 29-Feb-2024 |
| Exchange | BSE, NSE |
| Segment | Mainboard |
| Lead managers | JM Financial (left lead) |
How the GPT Healthcare Limited IPO was subscribed
| Category | Subscription |
|---|---|
| QIB | 17.30x |
| NII | 11.02x |
| Retail | 2.44x |
| Total | 8.52x |
GPT Healthcare Limited today
| Figure | Value |
|---|---|
| Market capitalisation | ₹1,242 Cr |
| Trailing P/E | 29.80x |
| Return on capital employed | 23.7% |
| Return on equity | 28.5% |
| 52-week high | ₹175 |
| 52-week low | ₹114 |
| Sector | Hospital |
Fundamentals are as of the desk's last harvest and move with the market.
- GPT Healthcare Limited — full issue page: every stored figure, with its source.
- How many IPOs still trade above their issue price, corporate-action adjusted.
- The full IPO archive: listing gains by year, sector and issue size.
Automated data digest. This page is compiled automatically from exchange filings and public aggregator data. It is a record of reported figures — it is not research, not a recommendation, and not investment advice.
Grey Market Premium (GMP) is an unofficial, unregulated price quoted outside the exchanges. It is not a forecast of the listing price and is frequently wrong.
Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Investments in securities markets are subject to market risk; read all offer documents carefully before investing. Registration granted by SEBI and NISM certification in no way guarantee performance or assure returns.